HC
AGN

Henshaw Capital’s Allergan plc AGN Stock Holding History

Henshaw Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,937
Closed -$284K – 309
2019
Q1 		$284K Buy
1,937
+435
+29% +$63.1K 0.02% 213
2018
Q4 		$201K Buy
1,502
+219
+17% +$35.9K 0.02% 254
2018
Q3 		$244K Buy
+1,283
New +$236K 0.02% 262

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Henshaw Capital's AGN Position: Q2 2019 in Review

Henshaw Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,937 shares — an estimated $284K sold.

Henshaw Capital first reported a position in AGN in Q3 2018 and held it in 3 quarters. The position peaked at $284K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Henshaw Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Henshaw Capital sold 1,937 Allergan plc shares in Q2 2019, an estimated $284K.
  • Henshaw Capital first reported a position in Allergan plc in Q3 2018 and held it in 3 quarters.
  • Henshaw Capital's Allergan plc position peaked at $284K in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Henshaw Capital's 13F filing for Q2 2019, filed 28 May 2026.